Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

2017 ◽  
Vol 67 (6) ◽  
pp. 1204-1212 ◽  
Author(s):  
Reem Waziry ◽  
Behzad Hajarizadeh ◽  
Jason Grebely ◽  
Janaki Amin ◽  
Matthew Law ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Direct Acting Antiviral ◽  
Hcv Therapy ◽  
Meta Regression ◽  
Meta Analyses ◽  
Direct Acting ◽  
Carcinoma Risk

The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk

2020 ◽  
Vol 27 (8) ◽  
pp. 781-793 ◽  
Author(s):  
Naveed Z. Janjua ◽  
Stanley Wong ◽  
Maryam Darvishian ◽  
Zahid A. Butt ◽  
Amanda Yu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
The Impact ◽  
Carcinoma Risk

scholarly journals Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy

2018 ◽  
Vol 48 (2) ◽  
pp. 127-137 ◽  
Author(s):  
N. Saraiya ◽  
A. C. Yopp ◽  
N. E. Rich ◽  
M. Odewole ◽  
N. D. Parikh ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Antiviral Therapy ◽  
Meta Analysis ◽  
Direct Acting Antiviral ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document